{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T04:04:18Z","timestamp":1774584258115,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000555","name":"British Microcirculation Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000555","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.beha.2020.101191","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T01:47:08Z","timestamp":1591580828000},"page":"101191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci"],"prefix":"10.1016","volume":"33","author":[{"given":"Hetty E.","family":"Carraway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"LaFramboise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.beha.2020.101191_bib1","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.beha.2020.101191_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"issue":"22","key":"10.1016\/j.beha.2020.101191_bib3","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.beha.2020.101191_bib4","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2020.101191_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jbi.2015.10.003","article-title":"Whole-exome sequencing enhances prognostic classification of myeloid malignancies","volume":"58","author":"Ruffalo","year":"2015","journal-title":"J Biomed Inf"},{"issue":"12","key":"10.1016\/j.beha.2020.101191_bib6","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1038\/leu.2017.266","article-title":"Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes","volume":"31","author":"Nazha","year":"2017","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.beha.2020.101191_bib7","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/cncr.20989","article-title":"A cohort study of cancer risk in relation to family histories of cancer in the Utah population database","volume":"103","author":"Kerber","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.beha.2020.101191_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00043426-199805000-00015","article-title":"Identical cytogenetic clones and clonal evolution in pediatric monozygotic twins with acute myeloid leukemia: presymptomatic disease detection by interphase fluorescence in situ hybridization and review of the literature","volume":"20","author":"Richkind","year":"1998","journal-title":"J Pediatr Hematol\/Oncol"},{"issue":"2","key":"10.1016\/j.beha.2020.101191_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.2011.37.1203","article-title":"Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes","volume":"30","author":"Goldin","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2020.101191_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fcell.2017.00111","article-title":"RUNX1 mutations in inherited and sporadic leukemia","volume":"5","author":"Bellissimo","year":"2017","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"10.1016\/j.beha.2020.101191_bib11","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1182\/blood-2008-05-156745","article-title":"Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy","volume":"112","author":"Owen","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2020.101191_bib12","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/sj.leu.2403945","article-title":"Risk factors of myelodysplastic syndromes: a case-control study","volume":"19","author":"Strom","year":"2005","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.beha.2020.101191_bib13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1200\/JCO.2016.70.8644","article-title":"Germline genetic predisposition to hematologic malignancy","volume":"35","author":"Furutani","year":"2017","journal-title":"J Clin Oncol : Off. J. Am. Soc. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.beha.2020.101191_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2017-02-735290","article-title":"Genetic predisposition to hematologic malignancies: management and surveillance","volume":"130","author":"Godley","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2020.101191_bib15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2018-10-844662","article-title":"Genetic predisposition to MDS: clinical features and clonal evolution","volume":"133","author":"Kennedy","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101191_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/nyas.12346","article-title":"Familial myelodysplastic syndrome\/acute leukemia syndromes: a review and utility for translational investigations","volume":"1310","author":"West","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.beha.2020.101191_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2015.17703","article-title":"Familial risk and heritability of cancer among twins in nordic countries","volume":"315","author":"Mucci","year":"2016","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.beha.2020.101191_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bjh.12492","article-title":"Genome-wide genotype-based risk model for survival in acute myeloid leukaemia patients with normal karyotype","volume":"163","author":"Choi","year":"2013","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.beha.2020.101191_bib19","doi-asserted-by":"crossref","first-page":"7891","DOI":"10.18632\/oncotarget.13631","article-title":"Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia","volume":"8","author":"Lv","year":"2017","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.beha.2020.101191_bib20","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2020.101191_bib21","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3324\/haematol.2016.149476","article-title":"Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients","volume":"101","author":"Keel","year":"2016","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.beha.2020.101191_bib22","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/s41375-018-0051-y","article-title":"Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?","volume":"32","author":"Tawana","year":"2018","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.beha.2020.101191_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062615","article-title":"Evaluating power and type 1 error in large pedigree analyses of binary traits","volume":"8","author":"Cummings","year":"2013","journal-title":"PloS One"},{"issue":"17","key":"10.1016\/j.beha.2020.101191_bib24","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood-2018-10-879585","article-title":"A gene-based recessive diplotype exome scan discovers FGF6, a novel hepcidin-regulating iron-metabolism gene","volume":"133","author":"Guo","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2020.101191_bib25","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.beha.2020.101191_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12185-010-0612-y","article-title":"T cell acute lymphoblastic leukemia arising from familial platelet disorder","volume":"92","author":"Nishimoto","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.beha.2020.101191_bib27","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1038\/ncomms5770","article-title":"Recurrent CDC25C mutations drive malignant transformation in FPD\/AML","volume":"5","author":"Yoshimi","year":"2014","journal-title":"Nat Commun"},{"issue":"22","key":"10.1016\/j.beha.2020.101191_bib28","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2015-04-641100","article-title":"Genomic analysis of germ line and somatic variants in familial myelodysplasia\/acute myeloid leukemia","volume":"126","author":"Churpek","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2020.101191_bib29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1055-9965.EPI-16-0520","article-title":"Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992-2013","volume":"26","author":"Noone","year":"2017","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"7616","key":"10.1016\/j.beha.2020.101191_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.beha.2020.101191_bib31","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.beha.2020.101191_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.beha.2020.101191_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ajhg.2018.02.019","article-title":"Identification of misclassified ClinVar variants via disease population prevalence","volume":"102","author":"Shah","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.beha.2020.101191_bib34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ajhg.2016.03.024","article-title":"Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the clinical sequencing exploratory research Consortium","volume":"98","author":"Amendola","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"7","key":"10.1016\/j.beha.2020.101191_bib35","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1634\/theoncologist.2016-0431","article-title":"Clinical variant classification: a comparison of public databases and a commercial testing laboratory","volume":"22","author":"Gradishar","year":"2017","journal-title":"Oncol"},{"issue":"3","key":"10.1016\/j.beha.2020.101191_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/gim.2017.269","article-title":"Interpretation of genomic sequencing: variants should be considered uncertain until proven guilty","volume":"20","author":"Weck","year":"2018","journal-title":"Genet Med"},{"issue":"13","key":"10.1016\/j.beha.2020.101191_bib37","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.beha.2020.101191_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"issue":"4","key":"10.1016\/j.beha.2020.101191_bib39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat Methods"},{"issue":"17","key":"10.1016\/j.beha.2020.101191_bib40","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the functional impact of protein mutations: application to cancer genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"10.1016\/j.beha.2020.101191_bib41","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","article-title":"PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels","volume":"31","author":"Choi","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.beha.2020.101191_bib42","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47(D1)","author":"Rentzsch","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.beha.2020.101191_bib43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41576-019-0177-4","article-title":"Rare-variant collapsing analyses for complex traits: guidelines and applications","volume":"20","author":"Povysil","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"26","key":"10.1016\/j.beha.2020.101191_bib49","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2020.101191_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.27464","article-title":"Hereditary breast cancer; Genetic penetrance and current status with BRCA","author":"Mahdavi","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.beha.2020.101191_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/gcc.22393","article-title":"Truncating and missense PPM1D mutations in early-onset and\/or familial\/hereditary prostate cancer patients","author":"Cardoso","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beha.2020.101191_bib65","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1611604","article-title":"Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation","author":"Lindsley","year":"2017","journal-title":"New England J. Medicine"},{"key":"10.1016\/j.beha.2020.101191_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2018.10.004","article-title":"PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy","author":"Hsu","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.beha.2020.101191_bib44","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1182\/blood.V88.11.4314.bloodjournal88114314","article-title":"Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders","volume":"88","author":"Miles","year":"1996","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2020.101191_bib45","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V96.6.2310","article-title":"Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cell","volume":"96","author":"Cooper","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2020.101191_bib46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","article-title":"DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions","volume":"130","author":"Buscarlet","year":"2017","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.beha.2020.101191_bib47","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.beha.2020.101191_bib48","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2020.101191_bib50","series-title":"Prevalence of inherited cancer predisposition mutations in a cohort of older AML patients enrolled on the beat AML master trial","author":"Borate","year":"2019"},{"issue":"2","key":"10.1016\/j.beha.2020.101191_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005965","article-title":"A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal","volume":"14","author":"Sun","year":"2018","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"10.1016\/j.beha.2020.101191_bib52","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.beha.2020.101191_bib53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3324\/haematol.2017.180778","article-title":"Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7","volume":"103","author":"Pastor","year":"2018","journal-title":"Haematologica"},{"issue":"21","key":"10.1016\/j.beha.2020.101191_bib54","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood-2017-05-787390","article-title":"Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes","volume":"132","author":"Nagata","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2020.101191_bib55","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng.334","article-title":"JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms","volume":"41","author":"Jones","year":"2009","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.beha.2020.101191_bib56","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ng.341","article-title":"A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms","volume":"41","author":"Olcaydu","year":"2009","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.beha.2020.101191_bib57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.342","article-title":"A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms","volume":"41","author":"Kilpivaara","year":"2009","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.beha.2020.101191_bib58","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2020.101191_bib59","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12859-019-3062-4","article-title":"CytoConverter: a web-based tool to convert karyotypes to genomic coordinates","volume":"20","author":"Wang","year":"2019","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.beha.2020.101191_bib60","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41375-019-0701-8","article-title":"Rare germline variant contributions to myeloid malignancy susceptibility","volume":"34(6)","author":"Li","year":"2020","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.beha.2020.101191_bib61","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2020.101191_bib62","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/bloodadvances.2017013037","article-title":"Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies","volume":"2","author":"Drazer","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2020.101191_bib67","doi-asserted-by":"crossref","DOI":"10.1177\/2324709620938941","article-title":"Inherited Thrombocytopenia Caused by Germline ANKRD2 Mutation Should be Considered in Young Patients with Suspected Myelodysplastic Syndrome","author":"Kewan","year":"2020","journal-title":"J Invest. Medicine High Impact Case Reports"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692620300529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692620300529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:06:50Z","timestamp":1761498410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692620300529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1521692620300529"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2020.101191","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2020.101191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101191"}}